4 free views remaining today
methotrexate-associated lymphoproliferation
Description
Signs and Symptoms
Methotrexate-associated lymphoproliferation, also known as MTX-LPD, can manifest with a range of signs and symptoms.
Common symptoms include:
- Swelling is the predominant manifestation of the disease [2].
- Abdominal pain
- Difficulty in breathing
- Distension of the abdomen
- Nausea
- Vomiting
- Fever
- Constant feeling of tiredness
- Night sweats
These symptoms can vary in severity and may be accompanied by other signs of lymphoproliferation, such as lymphadenopathy (enlarged lymph nodes) or splenomegaly (enlarged spleen).
Cutaneous manifestations:
- Nodules and/or erythematous plaques are common cutaneous manifestations of MTX-LPD [9].
- Serpentine vessels and fine short hair may be observed in cutaneous lymphomas.
It's essential to note that these symptoms can also be present in other conditions, and a definitive diagnosis of methotrexate-associated lymphoproliferation requires further evaluation and testing.
References: [2] - Swelling is the predominant manifestation of the disease. [9] - Cutaneous manifestations of MTX-LPD are nodules and/or erythematous plaques.
Additional Symptoms
- Swelling
- Difficulty in breathing
- Lymphadenopathy (enlarged lymph nodes)
- Cutaneous manifestations
- Splenomegaly (enlarged spleen)
- erythematous plaques
- Distension of the abdomen
- nodules
- serpentine vessels
- fine short hair
- nausea
- tiredness
- night sweats
- abdominal pain
- vomiting
- fever
Diagnostic Tests
Diagnostic Tests for Methotrexate-Associated Lymphoproliferative Disorder
Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is a rare and serious complication of methotrexate therapy. Accurate diagnosis is crucial to prevent further complications and initiate appropriate treatment.
Common Diagnostic Tests:
- Imaging techniques such as:
- Ultrasound (USG)
- Computed Tomography (CT-scan)
- Positron Emission Tomography/Computed Tomography (PET/CT) [5]
- Histopathological examination of biopsy samples to determine the type and extent of lymphoproliferation [8]
Other Diagnostic Tests:
- Serum Epstein-Barr nuclear antigen-antibody test
- Viral capsid antigen-IgG antibody test
- Contrast-enhanced abdominal computed tomography (CT) to detect tumors or lesions [14]
- Polymerase Chain Reaction (PCR) to detect clonal rearrangement of the T-cell receptor beta chain gene, consistent with T-cell lymphoma [15]
Importance of Diagnostic Tests:
Accurate diagnosis is essential to differentiate MTX-LPD from other diseases and determine the treatment strategy. Discontinuation of methotrexate can lead to remission in half of the patients with MTX-LPDs [12].
References: [5] Common diagnostic tests and procedures for diagnosing the methotrexate-associated lymphoproliferative disorder are;. Imaging techniques like USG, CT-scan, PET- ... [8] by M Suzuki · 2021 · Cited by 1 — Histopathological diagnosis is important for differentiating the diagnosis of MTX-LPD from other diseases and for determining the treatment strategy, however, ... [12] Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is a major complication of methotrexate (MTX) therapy that can develop in patients with rheumatoid arthritis (RA), although primary hepatic MTX-LPD is extremely rare. Discontinuation of MTX results in remission in half of the patients with MTX-LPDs and is one treatment approach. [14] The serum Epstein-Barr nuclear antigen‐antibody test and viral capsid antigen‐IgG antibody test had positive results. Contrast‐enhanced abdominal computed tomography (CT) revealed a 20‐mm‐diameter hypovascular tumor in the pancreatic tail (Figures 1a-d). The lesion was round in shape with a low‐density area suspected of necrosis ... [15] Furthermore, clonal rearrangement of the T-cell receptor beta chain gene was detected on PCR, consistent with T-cell lymphoma. On the basis of this immunophenotype and histopathological findings by hematoxylin and eosin staining, the diagnosis of MTX-associated angioimmunoblastic T-cell lymphoma-like lymphoproliferative disorder was established.
Treatment
Differential Diagnosis
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_11867
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:5821
- core#notation
- DOID:5821
- oboInOwl#hasDbXref
- UMLS_CUI:C1334749
- rdf-schema#label
- methotrexate-associated lymphoproliferation
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0060058
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.